Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

West Des Moines, Iowa 50266


Purpose:

Silodosin is compared to placebo to determine if it is safe and effective for the treatment of nighttime urination (nocturia) in men with BPH


Study summary:

This will be a multi-center, double-blind, placebo controlled, parallel, 12 week treatment trial in men with signs and symptoms of benign prostatic hyperplasia and nocturia. The following procedures are utilized; physical exams, electrocardiograms, clinical laboratory tests, vital signs, urinary diary, Pittsburgh Quality of Sleep Index, Nocturia Quality of Life


Criteria:

Inclusion Criteria: - Males in good general health and at least 50 years of age, with symptoms of moderate to severe BPH and nocturia (>=2 episodes per night) Exclusion Criteria: - Medical conditions that would confound the efficacy evaluation. - Medical conditions in which it would be unsafe to use an alpha-blocker. - The use of concomitant drugs that would confound the efficacy evaluation. - The use of concomitant drugs that would be unsafe with this alpha-blocker.


NCT ID:

NCT00793819


Primary Contact:

Study Director
Kim Caramelli, MS
Watson Pharmaceuticals


Backup Contact:

N/A


Location Contact:

West Des Moines, Iowa 50266
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.